ResMed
802 hedge funds and large institutions have $21.3B invested in ResMed in 2024 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 324 increasing their positions, 257 reducing their positions, and 73 closing their positions.
57% more funds holding in top 10
Funds holding in top 10: 7 → 11 (+4)
49% more first-time investments, than exits
New positions opened: 109 | Existing positions closed: 73
30% more capital invested
Capital invested by funds: $16.4B → $21.3B (+$4.85B)
26% more repeat investments, than reductions
Existing positions increased: 324 | Existing positions reduced: 257
4% more funds holding
Funds holding: 773 → 802 (+29)
0.93% more ownership
Funds ownership: 58.48% → 59.41% (+0.93%)
59% less call options, than puts
Call options by funds: $253M | Put options by funds: $619M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$241M |
| 2 |
Coatue Management
New York
|
+$106M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$85M |
| 4 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
+$55.7M |
| 5 |
BlackRock
New York
|
+$49.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$171M |
| 2 |
Goldman Sachs
New York
|
-$77.7M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$74.7M |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$72M |
| 5 |
Jane Street
New York
|
-$41M |
RMD Hedge Fund Activity: Q3 2024 in Review
802 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q3 2024, worth a combined $21.3B — up 30% from $16.4B a quarter earlier.
Buyers outnumbered sellers: 109 funds opened new RMD positions and 73 closed out — a net gain of 36 holders — while 324 added to existing stakes and 257 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $241M. The largest seller was Fidelity Investments, cutting an estimated $171M.
- 802 institutional investors held ResMed (RMD) as of Q3 2024, up from 773 in Q2 2024.
- Funds reported $21.3B of ResMed stock for Q3 2024, up 30% quarter-over-quarter.
- 109 funds opened new ResMed positions in Q3 2024 and 73 closed out, a net change of +36 holders.
- The largest ResMed buyer in Q3 2024 was Morgan Stanley, an estimated $241M added.
- The largest ResMed seller in Q3 2024 was Fidelity Investments, an estimated $171M sold.
Based on aggregated 13F filings for Q3 2024.